JP2010527344A5 - - Google Patents

Download PDF

Info

Publication number
JP2010527344A5
JP2010527344A5 JP2010507977A JP2010507977A JP2010527344A5 JP 2010527344 A5 JP2010527344 A5 JP 2010527344A5 JP 2010507977 A JP2010507977 A JP 2010507977A JP 2010507977 A JP2010507977 A JP 2010507977A JP 2010527344 A5 JP2010527344 A5 JP 2010527344A5
Authority
JP
Japan
Prior art keywords
independently
nhr
compound according
present
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010507977A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010527344A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2008/001683 external-priority patent/WO2008142376A1/en
Publication of JP2010527344A publication Critical patent/JP2010527344A/ja
Publication of JP2010527344A5 publication Critical patent/JP2010527344A5/ja
Pending legal-status Critical Current

Links

JP2010507977A 2007-05-18 2008-05-16 ビシクロスルホニル酸（ｂｃｓａ）化合物及び治療薬としてのその使用 Pending JP2010527344A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92451807P 2007-05-18 2007-05-18
PCT/GB2008/001683 WO2008142376A1 (en) 2007-05-18 2008-05-16 Bicyclosulfonyl acid (bcsa) compounds and their use as therapeutic agents

Publications (2)

Publication Number Publication Date
JP2010527344A JP2010527344A (ja) 2010-08-12
JP2010527344A5 true JP2010527344A5 (enExample) 2011-07-28

Family

ID=39740054

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010507977A Pending JP2010527344A (ja) 2007-05-18 2008-05-16 ビシクロスルホニル酸（ｂｃｓａ）化合物及び治療薬としてのその使用

Country Status (10)

Country Link
US (1) US20100311741A1 (enExample)
EP (1) EP2155703A1 (enExample)
JP (1) JP2010527344A (enExample)
KR (1) KR20100020479A (enExample)
AU (1) AU2008252628A1 (enExample)
BR (1) BRPI0811651A2 (enExample)
CA (1) CA2687415A1 (enExample)
MX (1) MX2009012470A (enExample)
RU (1) RU2472784C2 (enExample)
WO (1) WO2008142376A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2406248B1 (en) * 2009-03-11 2013-12-25 Msd K.K. Novel isoindolin-1-one derivative
GB2475359A (en) * 2009-11-11 2011-05-18 Biocopea Ltd A compound for use in treating a fulminant respiratory disorder
KR101822444B1 (ko) 2010-07-08 2018-01-26 가켄 세이야쿠 가부시키가이샤 N-히드록시포름아미드 유도체 및 그를 함유하는 의약
US20150125438A1 (en) 2012-07-20 2015-05-07 Sang Jae Kim Anti-Inflammatory Peptides and Composition Comprising the Same
CA2934391A1 (en) * 2013-12-20 2015-06-25 Bayer Pharma Aktiengesellschaft Glucose transport inhibitors
CN110790758A (zh) * 2018-08-01 2020-02-14 上海轶诺药业有限公司 一类具有免疫调节功能的含n杂环化合物的制备和应用
EP3750878B1 (en) 2019-06-14 2025-05-14 Vivoryon Therapeutics N.V. Heteroaromatic inhibitors of astacin proteinases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0350163A3 (en) * 1988-06-09 1990-11-22 Beecham Group Plc Renin inhibitory peptides
CA2006443A1 (en) * 1988-12-23 1990-06-23 Stephen A. Smith Compounds
AU653279B2 (en) * 1991-12-30 1994-09-22 Sanofi Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
ATE286892T1 (de) * 1997-11-12 2005-01-15 Darwin Discovery Ltd Hydroxam- und carbonsäurederivate mit mmp- und tnf-hemmender aktivität
US6288063B1 (en) * 1998-05-27 2001-09-11 Bayer Corporation Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
US6319912B1 (en) * 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
WO2002081447A1 (en) * 2001-04-06 2002-10-17 Daewoong Pharmaceutical Co., Ltd. 3-cyclopentyloxy-4-methoxyphenyl-isothiazolinone derivatives and the use thereof
WO2003031431A1 (en) * 2001-10-09 2003-04-17 Bristol-Myers Squibb Company Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
JP2007537978A (ja) * 2003-07-10 2007-12-27 ニューロジェン・コーポレーション アリール基で置換されたベンゾ［ｄ」イソチアゾール−３−イルアミン類縁体

Similar Documents

Publication Publication Date Title
JP7185681B2 (ja) 免疫調節化合物
AU2020275818B2 (en) Fluorine-containing compound and anti-cancer medical use thereof
US10550071B2 (en) PPAR agonists
CA2559036C (en) 9-substituted 8-oxoadenine compound
JP6409001B2 (ja) Ｈｂｖ感染に対する新規抗ウイルス剤
CA2903288C (en) N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
JP7440572B2 (ja) デュアルｍａｇｌ及びｆａａｈインヒビター
JP2023520925A5 (enExample)
AU2019201352A1 (en) Bromodomain inhibitors
JP2013525433A5 (enExample)
JP5998139B2 (ja) １，５−ジフェニル−ペンタ−１，４−ジエン−３−オン化合物
JP2011500539A5 (enExample)
WO2015085238A1 (en) Inhibitors of lpxc
RU2016115868A (ru) Замещенные гетероциклические сульфонамидные соединения, полезные в качестве модуляторов trpa 1
AU2016229136A1 (en) DNA alkylating agents
JP2009534407A5 (enExample)
CN118903087A (zh) 可用于预防或治疗疾病的官能化的长链烃一元和二元羧酸
JP2018534301A5 (enExample)
DE3340967A1 (de) Neue aminderivate, salze derselben, verfahren zur herstellung derselben sowie anti-ulcusmittel mit einem gehalt derselben
RU2009145296A (ru) Бициклосульфониловая кислота (bcsa) и ее применение в качестве терапевтического агента
JP2020529968A (ja) 置換５員および６員複素環式化合物、その調製方法、薬剤の組み合わせおよびその使用
US20180319836A1 (en) Bile acid derivatives and methods for synthesis and use
WO2017165822A1 (en) Small molecule inhibitor of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
EP3044223A2 (en) Substituted 2, 3-dihydro-1h-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis
US20170119795A1 (en) Fused triterpene compounds and uses thereof